Table 3 Economic contribution to Nicaragua. Source: Gavi’s Report [40]
From: Vaccine market and production capabilities in the Americas
| Type of support |
Approvals 2001–2023 (USD) |
Disbursements 2000–2019 (USD) |
|---|---|---|
| Health system strengthening (HSS 2) | $3,793,600 | $3,793,600 |
| Immunization services support (ISS) | $293,280 | $293,280 |
| Injection Safety Devices (NVS) | $74,000 | $74,000 |
| Injection safety support (INS) | $461,990 | $461,990 |
| Vaccine against Polio | $2,040,500 | $2,040,500 |
| Pneumo (NVS) | $16,361,767 | $17,915,772 |
| Rotavirus (NVS) | $14,024,262 | $12,729,500 |
| Vaccine Introduction Grant (VIG) | $309,935 | $309,935 |
| TOTAL | $37,359,334 | $37,618,577 |